2.Nephrectomy and removal of inferior vena cava tumor thrombus under profound hypothermia and arrested circulation
Yousheng YAO ; Jian HUANG ; Hai HUANG ; Yanqi YANG ; Shuling PENG ; Kewei XU ; Zhenghui GUO ; Tianxin LIN ; Chun JIANG ; Jinli HAN
Chinese Journal of Urology 2008;29(5):300-302
Objective To study the feasibility and safety of performing nephrectomy together with the removal of complicated inferior vena cava tumor thrombus under profound hypothermia and arrested circulation. Methods After made the median thoraco-abdominal incision, the exploration of the abdominal organs was done. The right kidney, inferior vena cava and renal pedicle were well exposed then. After the whole body heparinization, cannulas were put into ascending aorta, superior vena cava, aortic root and right superior pulmonary vein. The body temperature was reduced to 20℃ with cardiopulmonary bypass unit and the extracorporeal circulation was stopped then. Cut open the inferior vena cava at vena renalis dextra ingress and the F16 urinary catheter was inserted into atrum dextra through inferior vena cava and inflated. The tumor thrombus was pulled out and the right kidney was removed. The inferior vena cava incision was sutured to close and the extracorporeal circulation was resumed and patient was re-warmed.Results The operation time was 330 min and the extracorporeal circulation time was 90 min, while the profound hypothermia with circulatory arrest time was 20 min. The estimated blood loss during operation was 400 ml and 6 unit red cells and 600 ml blood plasm were transfused. The patient was awaked 2.5 h after the operation, food intake resumed 4 days after operation and the patient was discharged on day 10 post-operatively. After 6 months'follow-up, there were no local recurrence and metastasis occurred. Conclusion The technique of profound hypothermia and circulation arrest could improve the safety and efficacy in the treatment of renal cell carcinoma with suprahepatic (level Ⅲ) caval tumor thrombus.
3.Evolutionary analysis of neuraminidase gene of A/H7N9 influenza virus.
Yi-Tong SUN ; Neng-Zhi JIN ; Hai-Rong ZHANG ; Yu-Lin SHEN ; Yao MA ; Tian-Shu PENG
Chinese Journal of Virology 2014;30(1):44-50
In 2013, the World Health Organization reported the first case of human infection with a new influenza A (H7N9) virus in China. This has caused damage and panic within certain areas in China. Therefore, analysis of this virus with bioinformatics technology is very necessary. Neuraminidase (NA) is one of the most important antigens of the influenza virus and an important target for anti-flu drugs. In this study, the nucleotide and protein sequences of NA gene of A/H7N9 influenza viruses were retrieved from the NCBI database, and MEGA 5.0 software was employed to construct a phylogenetic tree based on the nucleotide coding sequence; BioEdit software was used to align the nucleotide and protein sequences of NA and calculate the homologies of nucleotides and amino acids and then to analyze the important mutation sites of NA gene. The results demonstrated that the spread of influenza virus H7N9 showed certain geographical and temporal relations. The H7N9 virus isolated from China in 2013 belonged to Euroasiatic serotype, and its NA stalk region hadobvious variation, which may be one of the reasons that this virus infects human. These analyses may be very helpful for understanding the evolutionary relationship and mutation trend of A/H7N9 influenza viruses.
Databases, Genetic
;
Evolution, Molecular
;
Humans
;
Influenza A Virus, H7N9 Subtype
;
enzymology
;
genetics
;
Mutation
;
Neuraminidase
;
chemistry
;
genetics
;
Phylogeny
;
Sequence Analysis
4.Treatment of bladder invasive adenosquamous carcinoma of the prostate: radical cystoprostatectomy.
Xu GAO ; Hai-Feng WANG ; Yun LI ; Song PENG ; Xin LU ; Zi-Yu FANG ; Yao-Ming LI ; Yan WANG ; Ying-Hao SUN
Chinese Medical Journal 2013;126(10):1998-1998
5.Molecular genetics and clinical features of nine patients with inherited coagulation factor VII deficiency.
Yan-hui JIN ; Ming-shan WANG ; Fang-xiu ZHENG ; Yao-sheng XIE ; Hai-xiao XIE ; Peng-fei XU
Chinese Journal of Medical Genetics 2012;29(4):404-407
OBJECTIVETo investigate potential mutations and clinical features of 9 unrelated patients with inherited coagulation factor VII (FVII) deficiency.
METHODSClinical diagnosis was validated by assaying of coagulation parameters including prothrombin time, activated partial thromboplastin time, FVII activity and specific antigens. All exons, exon-intron boundaries, and 5' and 3' untranslated regions of F7 genes were amplified with PCR. Potential mutations were detected by direct sequencing of purified PCR products. Suspected mutations were confirmed by sequencing of the opposite strand.
RESULTSAll probands have featured prolonged prothrombin time, with FVII activity ranging between 2.0% to 6.0%. The titers of FVII antigen were significantly reduced in 7 probands. Eight mutations, including 6 missense mutations, 1 deletion and 1 insertion, were identified, among which 3 (Gln100Leu, Ser269Pro and g.11520_11521insT) were not described previously. Six mutations have located in the protease domain. All mutations were inherited, and consanguineous marriages were reported in 5 families. Mutations g.27_28delCT, Cys329Gly, Arg304Trp and His348Gln have been identified in unrelated families. There was a lack of correlation between the mutations and their clinical features. Two individuals with homozygous His348Gln mutations and 1 individual with homozygous Arg304Trp mutation were only mildly affected or asymptomatic. Two patients, who have respectively carried homozygous and heterozygous deletions of g.27_28delCT, were moderately affected and asymptomatic. In 4 patients carrying double heterozygous mutations, 1 (Ser269Pro and Cys329Gly) was asymptomatic, 2 (Arg304Trp and Cys329Gly, Arg277Cys and g.11520_11521insT, respectively) had a mild bleeding tendency, whilst 1 (Gln100Leu and His348Gln) has a moderate bleeding diathesis.
CONCLUSIONThere seem to be hotspots of F7 gene mutations in ethnic Han Chinese populations. And there is a lack of correlation between particular types of mutations and clinical phenotypes.
Adolescent ; Adult ; Aged ; Base Sequence ; Blood Coagulation Disorders, Inherited ; genetics ; Child ; Factor VII ; genetics ; Factor VII Deficiency ; genetics ; Female ; Heterozygote ; Homozygote ; Humans ; Male ; Middle Aged ; Molecular Sequence Data ; Mutation ; Young Adult
6.Longbishu Capsule combined with mesylate doxazosin: an efficacious therapy for benign prostatic hyperplasia.
De-gui CHANG ; Guang-sen LI ; Cheng-hua PENG ; Xu-jun YU ; Pei-hai ZHANG ; Ming-shuai BI ; Di-ang CHEN ; Yao-dong YOU ; Xing-zhi YANG
National Journal of Andrology 2015;21(2):165-169
OBJECTIVETo assess the clinical effect and safety of the Chinese medicine Longbishu Capsule combined with mesylate doxazosin in the treatment of benign prostatic hyperplasia (BPH) of the kidney deficiency and blood stagnation type.
METHODSThis was a randomized, double-blind, double-simulation control study. We equally assigned 60 men diagnosed with BPH of the kidney deficiency and blood stagnation type to an experimental and a control group, the former treated with mesylate doxazosin plus Longbishu Capsule and the latter with mesylate doxazosin plus placebo. We compared the International Prostate Symptom Score (IPSS), quality of life (QOL), Chinese symptom score (CSS), maximal urinary flow rate (Qmax), and prostate volume between the two groups of patients before and after 6 months of medication.
RESULTSAfter treatment, there were 5 cured cases, 13 markedly effective cases, 9 effective cases, 1 ineffective case, and 2 eliminated cases in the experimental group, as compared with 2 cured cases, 8 markedly effective cases, 10 effective cases, 7 ineffective cases, and 3 eliminated cases in the control group. The total effectiveness rate was obviously higher in the former (96.4%) than in the latter (74.1%). IPSS, Qmax, and CSS were improved in both of the groups after medication, even more significantly in the experimental than in the control group (IPSS: 15.22 ± 2.98 vs 18.15 ± 5.88, P <0.05; Qmax: [13.56 ± 2.26] ml/s vs [11.78 ± 2.97] ml/s, P <0.05; CSS: 6.18 ± 2.13 vs 9.52 ± 3.15, P <0.05). Because of the difference in the QOL score between the two groups at the baseline (P = 0.038 <0.05), no more comparison was made in this aspect after treatment.
CONCLUSIONThe combination of Longbishu Capsule with mesylate doxazosin is safe and effective for the treatment of BPH.
Adrenergic alpha-Antagonists ; therapeutic use ; Capsules ; Double-Blind Method ; Doxazosin ; therapeutic use ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; therapeutic use ; Humans ; Male ; Prostatic Hyperplasia ; drug therapy ; physiopathology ; Quality of Life ; Treatment Outcome ; Urination
7.Hematologic parameters and genotype analysis in 166 children with HbH disease in the North Guangxi region.
Chun-Jiang ZHU ; Hui DING ; Hai-Qing ZHENG ; Juan PENG ; Wei-Lin OU ; Li-Bo YAO
Chinese Journal of Contemporary Pediatrics 2012;14(4):267-270
OBJECTIVETo study the characteristics of genotype spectrum and hematologic parameters in children with HbH disease in the North Guangxi region.
METHODSHbH disease was identified by clinical manifestations, routine blood tests and hemoglobin electrophoresis in 166 children who came form the North Guangxi region. Genotypes were determined by Multi-PCR combined with PCR reverse dot blot. DNA sequencing was used when the genotype could not be identified by regular methods.
RESULTSOf the 166 children with HbH disease, 8 genotypes were identified: --SEA/-α3.7 (82 cases), --SEA/-α4.2 (40 cases), --SEA/αCSα (38 cases), --SEA/αQSα (1 case), --SEA/αWSα (1 case), --SEA/αCD43/44 (-C) α (1 case), --SEA/-α3.7 plus CD17 (A→T) (1 case) and --SEA/-α4.2 plus CD41-42(-TTCT) (1 case). One case was confirmed as the heterozygote of --SEA and an unknown mutation. In the 134 cases with complete medical data, 2 had normal hemoglobin levels, 36 manifested mild anemia, 90 manifested moderate anemia, and 6 (genotype: --SEA/αCSα) showed severe anemia because of the coexistence of infection. Children with the genotype of --SEA/-α3.7 (69 cases), --SEA/-α4.2 (31 cases) and --SEA/αCSα (34 cases) had hemoglobin levels of 62-120, 69-127 and 34-110 g/L respectively. The hemoglobin level in the --SEA/αCSα group was significantly lower than in the deletional HbH disease group (genotypes: --SEA/-α3.7 and --SEA/-α4.2 ) (P<0.05). In contrast, MCV levels in the --SEA/αCSα group were significantly higher than in the deletional HbH disease group (P<0.05).
CONCLUSIONSThe genotype spectrum of HbH disease is diverse in the North Guangxi region. Deletional genotype is prevalent. The disease is heterogeneous. The children with --SEA/αCSα HbH disease have severer anemia and higher MCV levels than those with deletional HbH disease.
Adolescent ; Child ; Child, Preschool ; China ; Female ; Genetics, Population ; Genotype ; Hemoglobin H ; genetics ; Humans ; Infant ; Male ; Mutation ; alpha-Thalassemia ; blood ; genetics
8.The effects of natural polysaccharide supramolecular hydrogel on bacteriostatic activity and biofilm clearance of berberine
Yao-zhi ZHANG ; Xue-mei HUANG ; Ji-hui LU ; Xiao-yu LIN ; Lin-ying WU ; Hai-min LEI ; Peng-long WANG
Acta Pharmaceutica Sinica 2023;58(10):3099-3107
Taking berberine (BBR) as an example, to study whether the supramolecular hydrogel formed by berberine and lotus root starch (
9.Function of interferon-γ induced HepG2 cell apoptosis via inhibiting autophagy
Shi-Peng LI ; Zhen WANG ; Jin-Dan HE ; Yao YU ; Hai-Ming ZHANG ; Jian-Jun ZHANG
The Chinese Journal of Clinical Pharmacology 2017;33(4):343-346
Objective To explore the mechanism of interferon-γ (IFN-γ) induced HepG2 cell apoptosis by inhibiting autophagy via Stat1-IRF1 pathway.Methods HepG2 cells were divided into control group (0) and experimental groups within 9 different doses of IFN-γ (10,20,30,50,75,100,150,200,300 ng · mL-1).HepG2 cells were treated with IFN-γfor 24 h.The cell viability of HepG2 cells was measured with MTT assay.Apoptotic cells were detected by Annexin V-FITC/propidium iodide (PI) kit.The quantity and distribution of LC3 dots in HepG2 cells were observed by fluorescence microscope.The expressions of phospho-signal transducer and activator of transcription-1 (p-Stat1),interferon regulatory factor-1 (IRF1),oxidative stress-activated poly (ADP-ribose) polymerase-1 (PARP1),autophagy regulation factor Beclin1 (Beclin1),autophagy gene Atg5 (Atg5),microtubule-associated protein 1 light chain 3 (LC3),cystein-asparate protease 3 (Caspase-3) and Caspase-8 were detected by Western blotting.Results As compared with control group (100%),IFN-γwith seven different doses (30,50,75,100,150,200,300 ng · mL-1),could suppress the proliferation of HepG2.The survival rates of these seven different doses of IFN-γ were (86.33 ± 4.72)%,(78.12±5.56)%,(66.33 ±5.13)%,(50.33 ±6.65)%,(46.07 ± 1.03)%,(37.67 ±7.05)% and (31.33 ±3.51)%.The inhibitory effect significantly increased and the difference was statistically significant (P <0.01).As compared with that in the control group (3.77 ± 0.67)%,the apoptosis rate increased after the treatment with 100 ng · mL-1 IFN-γ which was (38.96 ±-4.35)%,and the difference between two groups was statistically significant (P <0.001).Moreover,there was a significant decrease of LC3 dots in 100 ng · mL-1 IFN-γ treated HepG2 cells 4.6 ± 1.1 as compared with that in the control group 15.6 ± 1.8,and the difference between two groups was statistically significant (P < 0.001).HepG2 cells were treated with 100 ng · mL-1 IFN-γfor 24 h,then the expression of p-Stat1,IRF1,PARP1,Cleave Caspase-3 and Cleave Caspase-8 up-regulated,while the expression of Beclin1,Atg5,and LC3Ⅱdown-regulated.Conclusion IFN-γ could induce HepG2 cell apoptosis via inhibiting autophagy,which may be related to stimulating Stat1-IRF1 signaling pathway.
10.Integrated Optical and Magnetic Navigation for Simplified Percutaneous Transforaminal Endoscopic Lumbar Discectomy: A Novel Approach
Xing-Chen YAO ; Jun-Peng LIU ; Xin-Ru DU ; Li GUAN ; Yong HAI ; Jincai YANG ; Aixing PAN
Neurospine 2025;22(1):297-307
Objective:
This study aims to evaluate the clinical benefits of the integrated optical and magnetic surgical navigation system in assisting transforaminal endoscopic lumbar discectomy (TELD) for the treatment of lumbar disc herniation (LDH).
Methods:
A retrospective analysis was conducted on patients who underwent TELD for LDH at Beijing Chaoyang Hospital, Capital Medical University from November 2022 to December 2023. Patients treated with the integrated optical and magnetic surgical navigation system were defined as the navigation-guided TELD (Ng-TELD) group (30 cases), while those treated with the conventional x-ray fluoroscopy method were defined as the control group (31 cases). Record and compare baseline characteristics, surgical parameters, efficacy indicators, and adverse events between the 2 patient groups.
Results:
The average follow-up duration for the 61 patients was 11.8 months. Postoperatively, both groups exhibited significant relief from back and leg pain, which continued to improve over time. At the final follow-up, patients’ lumbar function and quality of life had significantly improved compared to preoperative levels (p < 0.05). The Ng-TELD group had significantly shorter total operation time (58.43 ± 12.37 minutes vs. 83.23 ± 25.90 minutes), catheter placement time (5.83 ± 1.09 minutes vs. 15.94 ± 3.00 minutes), decompression time (47.17 ± 11.98 minutes vs. 67.29 ± 24.23 minutes), and fewer intraoperative fluoroscopies (3.20 ± 1.45 vs. 16.58 ± 4.25) compared to the control group (p < 0.05). There were no significant differences between the groups in terms of efficacy evaluation indicators and hospital stay. At the final follow-up, the excellent and good rate of surgical outcomes assessed by the MacNab criteria was 98.4%, and the overall adverse event rate was 8.2%, with no statistically significant differences between the groups (p > 0.05).
Conclusion
This study demonstrates that the integrated optical and magnetic surgical navigation system can reduce the complexity of TELD, shorten operation time, and minimize radiation exposure for the surgeon, highlighting its promising clinical potential.